A PHASE 3, MULTI-CENTER, NON-COMPARATIVE STUDY TO EVALUATE THE CONTRACEPTIVE EFFICACY, SAFETY, AND TOLERABILITY OF LPRI-CF113 ADMINISTERED ORALLY FOR 13 MEDICATION CYCLES

Registry ID

CF113-303

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

CHEMO RESEARCH, S.L.

Start date

2024-06-21

Last update

2022-09-21

Conditions

• CONTRACEPTION

Related clinical trials

• ESTETROL DROSPIRENONE TO REDUCE THE AVERAGE SIZE OF ENDOMETRIOMAS (ERASE)

View on source registry